Literature DB >> 28568483

Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state.

Armin Rashidi1, Alaa M Ali2, Kiran R Vij3, Ryan Shanley4, Rizwan Romee2, Sarah A Cooley1, Peter Westervelt2, John F DiPersio2, Jeffrey S Miller1, Daniel J Weisdorf1, Celalettin Ustun1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28568483      PMCID： PMC5736150          DOI： 10.1002/ajh.24804

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Successful nonmyeloablative allogeneic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis.

Authors:  C Q Xun; P A McSweeney; M Boeckh; R F Storb; V C Broudy; J A Thompson
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

2.  Conditioning with fludarabine alone and allogeneic transplantation as a successful rescue therapy for persistent, severe iatrogenic aplasia after relapse of acute myeloid leukemia.

Authors:  V Lazarevic; A Wahlin
Journal:  Bone Marrow Transplant       Date:  2006-11-20       Impact factor: 5.483

3.  Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia.

Authors:  Dominik Schneidawind; Birgit Federmann; Christoph Faul; Wichard Vogel; Lothar Kanz; Wolfgang Andreas Bethge
Journal:  Ann Hematol       Date:  2013-05-08       Impact factor: 3.673

4.  Persistent aplasia after chemotherapy for acute myeloid leukaemia treated with stem cell transplantation from a matched unrelated donor after dose-reduced conditioning.

Authors:  Lothar Hambach; Gerhard Heil; Bernd Hertenstein; Arnold Ganser
Journal:  Br J Haematol       Date:  2002-08       Impact factor: 6.998
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.